167 related articles for article (PubMed ID: 26206114)
1. Efficacy, safety, and outcomes in 17 pediatric cases treated with the free radical scavenger edaravone.
Nakamoto H; Aihara Y; Yamaguchi K; Kawamata T; Okada Y
Childs Nerv Syst; 2015 Sep; 31(9):1533-40. PubMed ID: 26206114
[TBL] [Abstract][Full Text] [Related]
2. Edaravone Reduces Hyperperfusion-Related Neurological Deficits in Adult Moyamoya Disease: Historical Control Study.
Uchino H; Nakayama N; Kazumata K; Kuroda S; Houkin K
Stroke; 2016 Jul; 47(7):1930-2. PubMed ID: 27174526
[TBL] [Abstract][Full Text] [Related]
3. Stroke in a child safely treated with intravenous tissue plasminogen activator and edaravone, a free radical scavenger.
Baba H; Sugimori H; Nanishi E; Nagata H; Lee S; Kuwashiro T; Hashizume M
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):903.e5-8. PubMed ID: 21421331
[TBL] [Abstract][Full Text] [Related]
4. Effect of edaravone on the estimated glomerular filtration rate in patients with acute ischemic stroke and chronic kidney disease.
Tsukamoto Y; Takizawa S; Takahashi W; Mase H; Miyachi H; Miyata T; Takagi S
J Stroke Cerebrovasc Dis; 2011; 20(2):111-6. PubMed ID: 20580255
[TBL] [Abstract][Full Text] [Related]
5. The synergetic effect of edaravone and borneol in the rat model of ischemic stroke.
Wu HY; Tang Y; Gao LY; Sun WX; Hua Y; Yang SB; Zhang ZP; Liao GY; Zhou QG; Luo CX; Zhu DY
Eur J Pharmacol; 2014 Oct; 740():522-31. PubMed ID: 24975100
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of edaravone, a free radical scavenger, for the treatment of acute lacunar infarction.
Mishina M; Komaba Y; Kobayashi S; Tanaka N; Kominami S; Fukuchi T; Mizunari T; Hamamoto M; Teramoto A; Katayama Y
Neurol Med Chir (Tokyo); 2005 Jul; 45(7):344-8; discussion 348. PubMed ID: 16041179
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of edaravone in cardioembolic stroke.
Inatomi Y; Takita T; Yonehara T; Fujioka S; Hashimoto Y; Hirano T; Uchino M
Intern Med; 2006; 45(5):253-7. PubMed ID: 16595989
[TBL] [Abstract][Full Text] [Related]
8. Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5).
Yamaguchi T; Awano H; Matsuda H; Tanahashi N;
J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):756-765. PubMed ID: 27887792
[TBL] [Abstract][Full Text] [Related]
9. Acute kidney injury and edaravone in acute ischemic stroke: the Fukuoka Stroke Registry.
Kamouchi M; Sakai H; Kiyohara Y; Minematsu K; Hayashi K; Kitazono T
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e470-6. PubMed ID: 23800495
[TBL] [Abstract][Full Text] [Related]
10. Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4.
Kikuchi K; Tancharoen S; Matsuda F; Biswas KK; Ito T; Morimoto Y; Oyama Y; Takenouchi K; Miura N; Arimura N; Nawa Y; Meng X; Shrestha B; Arimura S; Iwata M; Mera K; Sameshima H; Ohno Y; Maenosono R; Tajima Y; Uchikado H; Kuramoto T; Nakayama K; Shigemori M; Yoshida Y; Hashiguchi T; Maruyama I; Kawahara K
Biochem Biophys Res Commun; 2009 Dec; 390(4):1121-5. PubMed ID: 19737535
[TBL] [Abstract][Full Text] [Related]
11. Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain.
Zhang W; Sato K; Hayashi T; Omori N; Nagano I; Kato S; Horiuchi S; Abe K
Neurol Res; 2004 Apr; 26(3):342-8. PubMed ID: 15142331
[TBL] [Abstract][Full Text] [Related]
12. Edaravone in acute ischemic stroke.
Kitagawa Y
Intern Med; 2006; 45(5):225-6. PubMed ID: 16595983
[No Abstract] [Full Text] [Related]
13. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model.
Ueno Y; Zhang N; Miyamoto N; Tanaka R; Hattori N; Urabe T
Neuroscience; 2009 Aug; 162(2):317-27. PubMed ID: 19409967
[TBL] [Abstract][Full Text] [Related]
14. Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion.
Toyoda K; Fujii K; Kamouchi M; Nakane H; Arihiro S; Okada Y; Ibayashi S; Iida M
J Neurol Sci; 2004 Jun; 221(1-2):11-7. PubMed ID: 15178207
[TBL] [Abstract][Full Text] [Related]
15. Edaravone, a free radical scavenger, attenuates cerebral infarction and hemorrhagic infarction in rats with hyperglycemia.
Okamura K; Tsubokawa T; Johshita H; Miyazaki H; Shiokawa Y
Neurol Res; 2014 Jan; 36(1):65-9. PubMed ID: 24074041
[TBL] [Abstract][Full Text] [Related]
16. Effect of edaravone, a free radical scavenger, on ischemic cerebral edema assessed by magnetic resonance imaging.
Suda S; Igarashi H; Arai Y; Andou J; Chishiki T; Katayama Y
Neurol Med Chir (Tokyo); 2007 May; 47(5):197-201; discussion 201-2. PubMed ID: 17527045
[TBL] [Abstract][Full Text] [Related]
17. [Outcome assessment in treatment of edaravone in childhood ischemic stroke].
Osaka H; Okazaki S
No To Hattatsu; 2008 Sep; 40(5):403-5. PubMed ID: 18807890
[No Abstract] [Full Text] [Related]
18. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters.
Edaravone Acute Infarction Study Group
Cerebrovasc Dis; 2003; 15(3):222-9. PubMed ID: 12715790
[TBL] [Abstract][Full Text] [Related]
19. Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial).
Shinohara Y; Saito I; Kobayashi S; Uchiyama S
Cerebrovasc Dis; 2009; 27(5):485-92. PubMed ID: 19321945
[TBL] [Abstract][Full Text] [Related]
20. Does functional outcome in acute ischaemic stroke patients correlate with the amount of free-radical scavenger treatment? A retrospective study of edaravone therapy.
Unno Y; Katayama M; Shimizu H
Clin Drug Investig; 2010; 30(3):143-55. PubMed ID: 20155987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
